A detailed history of Richwood Investment Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Richwood Investment Advisors, LLC holds 3,432 shares of BIIB stock, worth $495,615. This represents 0.55% of its overall portfolio holdings.

Number of Shares
3,432
Previous 3,854 10.95%
Holding current value
$495,615
Previous $893,000 25.53%
% of portfolio
0.55%
Previous 0.78%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$189.07 - $236.8 $79,787 - $99,929
-422 Reduced 10.95%
3,432 $665,000
Q2 2024

Jul 26, 2024

SELL
$190.52 - $236.72 $381 - $473
-2 Reduced 0.05%
3,854 $893,000
Q1 2024

May 13, 2024

SELL
$212.02 - $267.71 $9,328 - $11,779
-44 Reduced 1.13%
3,856 $831,000
Q4 2023

Feb 09, 2024

SELL
$222.59 - $267.94 $23,817 - $28,669
-107 Reduced 2.67%
3,900 $1.01 Million
Q3 2023

Oct 30, 2023

SELL
$253.3 - $285.89 $36,728 - $41,454
-145 Reduced 3.49%
4,007 $1.03 Million
Q2 2023

Jul 21, 2023

SELL
$275.25 - $318.06 $24,497 - $28,307
-89 Reduced 2.1%
4,152 $1.18 Million
Q1 2023

Apr 19, 2023

SELL
$256.56 - $292.34 $145,726 - $166,049
-568 Reduced 11.81%
4,241 $1.18 Million
Q4 2022

Feb 08, 2023

SELL
$252.44 - $306.72 $23,729 - $28,831
-94 Reduced 1.92%
4,809 $1.33 Million
Q3 2022

Oct 27, 2022

SELL
$194.69 - $268.46 $79,628 - $109,800
-409 Reduced 7.7%
4,903 $1.31 Million
Q2 2022

Jul 22, 2022

BUY
$187.54 - $223.02 $15,940 - $18,956
85 Added 1.63%
5,312 $1.08 Million
Q1 2022

Apr 28, 2022

SELL
$193.77 - $244.14 $11,432 - $14,404
-59 Reduced 1.12%
5,227 $1.1 Million
Q4 2021

Feb 17, 2022

BUY
$223.92 - $287.77 $1.18 Million - $1.52 Million
5,286 New
5,286 $1.27 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $20.8B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Richwood Investment Advisors, LLC Portfolio

Follow Richwood Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Richwood Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Richwood Investment Advisors, LLC with notifications on news.